Repare Therapeutics (NASDAQ:RPTX) reported its Q4 earnings results on Wednesday, February 28, 2024 at 07:05 AM.
Here's what investors need to know about the announcement.
Earnings
Repare Therapeutics missed estimated earnings by -46.0%, reporting an EPS of $-0.67 versus an estimate of $-0.46.
Revenue was down $5.15 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.41 which was followed by a 5.0% increase in the share price the next day.
Here's a look at Repare Therapeutics's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.86 | -0.78 | -0.81 | -0.97 |
| EPS Actual | -0.45 | -0.28 | -0.83 | -0.75 |
| Revenue Estimate | 6.31M | 7.68M | 6.12M | 10.83M |
| Revenue Actual | 2.16M | 30.25M | 5.68M | 18.20M |
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Repare Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.